ArticleBMC oral health2026
In situ onlay bone grafting in the anterior maxilla: a retrospective study comparing two surgical techniques with a mean 42 months follow-up.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundAutologous bone grafting is considered as "gold standard" in the alveolar ridge augmentation techniques. In situ onlay grafting uses grafts adjacent to edentulous sites without a separate donor site. Several studies have revealed the satisfactory short-term performance of this less invasive modified technique, but no information is available of stability of alveolar ridge reconstructed by in situ onlay grafting and implant performance after occlusal loading in a mid-term follow-up. This study is to retrospectively evaluate the radiographic and patient reported outcomes (PROMs) of a modified onlay grafting technique and the subsequent implantation in anterior maxilla using in situ grafts without a second bone harvesting region.
methodsA total of 83 patients contributed 119 edentulous deficiency sites, and 104 implants were placed in anterior maxilla. 44 patients received in situ onlay grafting using subnasal grafts and 39 patients received ex situ onlay grafting using mandibular symphysis grafts. Alveolar ridge height and multileveled widths were assessed using cone-beam computed tomography (CBCT) prior grafting and at five subsequent time points. Clinical parameters and PROMs were evaluated with a visual analog scale (VAS) during the follow-up. Approximately 6 months after onlay grafting, dental implants were placed followed by fixed prosthetic rehabilitation. Implant survival and success rates were assessed with a mean follow-up of 42.90 months.
resultsThe horizontal bone resorption at cervical level after 1-year occlusal loading of in situ group (1.73% ± 1.29%) was lower than that of ex situ (3.85% ± 1.50%) group (P = 0.04). No other significant difference regarding bone resorption was found. The patient reported pain scores at 7 days after surgery of in situ group (2.43 ± 1.17) was lower than that of ex situ group (3.47 ± 2.08, P = 0.02). No implant loss was observed. The implant success rates were 96.36% in in-situ group and 97.96% in ex-situ group.
conclusionsWithin the limitations of the present retrospective study, the findings suggest that in situ onlay grafting may be a promising approach for reconstructing the anterior maxillary alveolar ridge and facilitating subsequent implant placement. These preliminary results are hypothesis-generating and warrant further validation through prospective, long-term investigations.
trial registrationThis study was retrospectively registered in Chinese Clinical Trial Registry (Registration number: ChiCTR2400083954, Registration date: 2024-05-08).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.